Positron emission tomography. A new tool for characterization of malignant disease and selection of therapy

Area of Science:

• Oncology
• Medical Imaging
• Biochemistry

Background:

• Current cancer therapy relies heavily on tumor histology and anatomy.
• Clinicians face challenges in assessing tumor biology and predicting treatment response.
• Metabolic imaging presents a novel approach to overcome these limitations.

Purpose of the Study:

• To explore the potential of positron emission tomography (PET) in oncology.
• To evaluate PET's ability to assess tumor biology, aggressiveness, and treatment response.
• To highlight PET as a complementary tool to anatomical imaging.

Main Methods:

• Utilizing positron emission tomography (PET) for metabolic imaging.
• Analyzing parameters such as glucose metabolism, hemodynamics, oxygen utilization, protein synthesis, and thymidine incorporation.
• Investigating tumor hypoxia and estrogen receptor density.

Main Results:

• PET can provide valuable data on tumor aggressiveness and stage.
• Early assessment of tumor response to treatment is possible before morphological changes.
• Metabolic markers can predict response to specific therapies, guiding treatment selection.

Conclusions:

• Positron emission tomography (PET) offers vital complementary information to anatomical imaging in oncology.
• PET aids oncologists in the optimal management of cancer patients.
• Further clinical validation is needed to fully integrate PET into routine practice.